475 related articles for article (PubMed ID: 18751917)
1. The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans.
Leitinger N
Subcell Biochem; 2008; 49():325-50. PubMed ID: 18751917
[TBL] [Abstract][Full Text] [Related]
2. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory profile of oxidized phospholipids.
Bochkov VN
Thromb Haemost; 2007 Mar; 97(3):348-54. PubMed ID: 17334500
[TBL] [Abstract][Full Text] [Related]
4. Atherosclerosis in patients with autoimmune disorders.
Frostegård J
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1776-85. PubMed ID: 15976324
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effects of oxysterols associated with human diseases: Induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis.
Vejux A; Lizard G
Mol Aspects Med; 2009 Jun; 30(3):153-70. PubMed ID: 19248805
[TBL] [Abstract][Full Text] [Related]
6. Infections and autoimmune diseases.
Bach JF
J Autoimmun; 2005; 25 Suppl():74-80. PubMed ID: 16278064
[TBL] [Abstract][Full Text] [Related]
7. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
9. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis.
Abou-Raya A; Abou-Raya S
Autoimmun Rev; 2006 May; 5(5):331-7. PubMed ID: 16782558
[TBL] [Abstract][Full Text] [Related]
10. Oxidatively modified autoantigens in autoimmune diseases.
Kurien BT; Hensley K; Bachmann M; Scofield RH
Free Radic Biol Med; 2006 Aug; 41(4):549-56. PubMed ID: 16863987
[TBL] [Abstract][Full Text] [Related]
11. Preventing autoimmune and infection triggered atherosclerosis for an enduring healthful lifestyle.
Matsuura E; Kobayashi K; Lopez LR
Autoimmun Rev; 2008 Jan; 7(3):214-22. PubMed ID: 18190881
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of lymphocyte migration in autoimmune disease.
Norman MU; Hickey MJ
Tissue Antigens; 2005 Sep; 66(3):163-72. PubMed ID: 16101827
[TBL] [Abstract][Full Text] [Related]
13. Tobacco smoking and autoimmune rheumatic diseases.
Harel-Meir M; Sherer Y; Shoenfeld Y
Nat Clin Pract Rheumatol; 2007 Dec; 3(12):707-15. PubMed ID: 18037930
[TBL] [Abstract][Full Text] [Related]
14. Oxidized phospholipids as triggers of inflammation in atherosclerosis.
Leitinger N
Mol Nutr Food Res; 2005 Nov; 49(11):1063-71. PubMed ID: 16270279
[TBL] [Abstract][Full Text] [Related]
15. Oxidative Phospholipidomics in health and disease: Achievements, challenges and hopes.
Reis A
Free Radic Biol Med; 2017 Oct; 111():25-37. PubMed ID: 28088624
[TBL] [Abstract][Full Text] [Related]
16. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease.
Tsimikas S; Tsironis LD; Tselepis AD
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2094-9. PubMed ID: 17626905
[TBL] [Abstract][Full Text] [Related]
17. Para-inflammation in the aging retina.
Xu H; Chen M; Forrester JV
Prog Retin Eye Res; 2009 Sep; 28(5):348-68. PubMed ID: 19560552
[TBL] [Abstract][Full Text] [Related]
18. Where the immune response meets the vessel wall.
Bisoendial RJ; Stroes ES; Tak PP
Neth J Med; 2009 Sep; 67(8):328-33. PubMed ID: 19767659
[TBL] [Abstract][Full Text] [Related]
19. Accelerated atherosclerosis in patients with systemic autoimmune diseases.
de Leeuw K; Kallenberg C; Bijl M
Ann N Y Acad Sci; 2005 Jun; 1051():362-71. PubMed ID: 16126978
[TBL] [Abstract][Full Text] [Related]
20. [Cardiovascular risk in autoimmune and inflammatory disorders].
Peeters MA; Chizzolini C
Rev Med Suisse; 2011 Apr; 7(291):867-71. PubMed ID: 21598728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
